AlloVir, Inc.
NASDAQ:ALVR
0.3811 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 8.38 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.165 |
| Cost of Revenue
| 0 | 0 | 0 | 0.141 | 3.643 | 0 | 0.547 | 1.094 | 0.199 | 0.426 | 0.846 | 0.554 | 0.044 | 0.033 | 0.018 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0 | 8.239 | -3.643 | 0 | -0.547 | -1.094 | -0.199 | -0.426 | -0.846 | -0.554 | -0.044 | -0.033 | -0.018 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.165 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0.983 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Reseach & Development Expenses
| -0.246 | 0.093 | 12.173 | 33.231 | 34.156 | 31.31 | 30.718 | 28.42 | 30.004 | 31.379 | 29.067 | 41.603 | 33.062 | 25.677 | 20.393 | 16.757 | 17.182 | 8.885 | 6.839 | 6.687 | 5.655 | 2.755 | 1.151 |
| General & Administrative Expenses
| 5.883 | 7.169 | 10.662 | 10.464 | 12.805 | 15.994 | 12.513 | 12.014 | 12.946 | 13.245 | 14.126 | 14.193 | 12.442 | 11.978 | 10.47 | 8.659 | 6.718 | 3.268 | 3.001 | 2.818 | 2.823 | 3.19 | 1.787 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 5.883 | 7.169 | 10.662 | 10.464 | 12.805 | 15.994 | 12.513 | 12.014 | 12.946 | 13.245 | 14.126 | 14.193 | 12.442 | 11.978 | 10.47 | 8.659 | 6.718 | 3.268 | 3.001 | 2.818 | 2.823 | 3.19 | 1.787 |
| Other Expenses
| 0.083 | 0 | 0.754 | 1.212 | 1.167 | 0.521 | 0.723 | 0.985 | 0.21 | -0.027 | -0.818 | -1.22 | -0.259 | -0.408 | -0.565 | -0.378 | 0.174 | 0.355 | 0.044 | 0.097 | 0.427 | 0.14 | 0.133 |
| Operating Expenses
| 5.72 | 7.262 | 22.835 | 43.695 | 46.961 | 47.304 | 43.231 | 40.434 | 42.95 | 44.624 | 43.193 | 55.796 | 45.504 | 37.655 | 30.863 | 25.416 | 23.9 | 12.153 | 9.84 | 9.505 | 8.478 | 5.945 | 2.938 |
| Operating Income
| -5.72 | -7.262 | -22.835 | -43.836 | -46.961 | -47.304 | -43.231 | -40.434 | -42.95 | -44.624 | -43.193 | -55.796 | -45.504 | -37.655 | -30.863 | -25.416 | -23.9 | -12.153 | -9.84 | -9.505 | -8.478 | -5.945 | -2.773 |
| Operating Income Ratio
| 0 | 0 | 0 | -5.231 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -16.806 |
| Total Other Income Expenses Net
| 1.594 | 1.186 | -7.464 | -15.986 | 2.689 | 2.037 | 2.048 | 1.883 | 0.878 | 0.135 | -0.67 | -1.138 | -0.006 | 0.067 | -0.06 | 0.217 | 0.286 | 0.521 | 0.501 | 0.762 | 1.208 | 0.643 | 0.249 |
| Income Before Tax
| -4.126 | -6.076 | -30.299 | -59.822 | -44.272 | -45.267 | -41.183 | -38.551 | -42.072 | -44.489 | -43.863 | -56.934 | -45.51 | -37.588 | -30.923 | -25.199 | -23.614 | -11.632 | -9.339 | -8.743 | -7.27 | -5.302 | -2.524 |
| Income Before Tax Ratio
| 0 | 0 | 0 | -7.139 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.297 |
| Income Tax Expense
| 0 | 0 | -0.1 | -0.126 | -0.086 | -1.516 | -2.048 | -0.415 | -0.878 | 0.15 | 0.67 | 1.007 | -0.253 | -0.475 | -0.505 | -0.613 | -0.13 | -0.185 | -0.457 | -0.665 | -9.259 | -6.448 | -1.903 |
| Net Income
| -4.126 | -6.076 | -30.299 | -59.696 | -44.272 | -45.267 | -39.135 | -38.136 | -41.194 | -44.639 | -44.533 | -57.941 | -45.51 | -37.588 | -30.923 | -25.199 | -23.614 | -11.632 | -9.339 | -8.743 | -7.27 | -5.302 | -2.524 |
| Net Income Ratio
| 0 | 0 | 0 | -7.124 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.297 |
| EPS
| -0.036 | -0.053 | -0.26 | -0.52 | -0.39 | -0.48 | -0.42 | -0.41 | -0.48 | -0.69 | -0.7 | -0.92 | -0.72 | -0.6 | -0.5 | -0.41 | -0.58 | -0.19 | -0.22 | -0.21 | -0.17 | -0.13 | -0.06 |
| EPS Diluted
| -0.036 | -0.053 | -0.26 | -0.52 | -0.39 | -0.48 | -0.42 | -0.41 | -0.48 | -0.69 | -0.7 | -0.92 | -0.72 | -0.6 | -0.5 | -0.41 | -0.58 | -0.19 | -0.22 | -0.21 | -0.17 | -0.13 | -0.06 |
| EBITDA
| -5.637 | -7.774 | -22.736 | -43.695 | -46.961 | -47.219 | -43.231 | -40.348 | -42.865 | -44.538 | -42.727 | -55.702 | -45.46 | -37.622 | -30.845 | -25.398 | -23.882 | -12.134 | -9.822 | -9.5 | 1.208 | 0.643 | 0.249 |
| EBITDA Ratio
| 0 | 0 | 0 | -5.214 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -16.806 |